1 |
Raony Í, Domith I, Lourenco MV, Paes-de-Carvalho R, Pandolfo P. Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110555. [PMID: 35346791 DOI: 10.1016/j.pnpbp.2022.110555] [Reference Citation Analysis]
|
2 |
Alnefeesi Y, Tamura JK, Lui LMW, Jawad MY, Ceban F, Ling S, Nasri F, Rosenblat JD, McIntyre RS. Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review. Neurosci Biobehav Rev 2021;131:192-210. [PMID: 34537265 DOI: 10.1016/j.neubiorev.2021.09.020] [Reference Citation Analysis]
|
3 |
Kantrowitz JT. Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions. CNS Drugs 2021;35:1153-61. [PMID: 34655036 DOI: 10.1007/s40263-021-00864-3] [Reference Citation Analysis]
|
4 |
Freyberg Z, Saavedra JM. Trace Amines and Trace Amine-Associated Receptors: A New Frontier in Cell Signaling. Cell Mol Neurobiol 2020;40:189-90. [PMID: 32006222 DOI: 10.1007/s10571-020-00800-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
de Bartolomeis A, Barone A, Begni V, Riva MA. Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacol Res 2022;:106078. [PMID: 35026403 DOI: 10.1016/j.phrs.2022.106078] [Reference Citation Analysis]
|